Stock Ideas
Stocks
Funds
Screener
Sectors
Watchlists
IOVA

IOVA - Iovance Biotherapeutics Inc Stock Price, Fair Value and News

7.97USD-0.03 (-0.38%)Market Closed

Latest Insider Trading transactions for IOVA

Datesorted ascendingNameBuy/Sell$ Value# SharesAvg. PriceTitle
2024-06-03 Premium
sold (taxes)
Premium Premium PremiumChief Medical Officer
2024-06-03 Premium
acquired
Premium Premium PremiumChief Medical Officer
2024-06-03 Premium
sold (taxes)
Premium Premium PremiumInterim CEO & General Counsel
2024-06-03 Premium
acquired
Premium Premium PremiumInterim CEO & General Counsel
2024-06-03 Premium
sold (taxes)
Premium Premium PremiumChief Operating Officer
2024-06-03 Premium
acquired
Premium Premium PremiumChief Operating Officer
2024-04-15 Premium
sold (taxes)
Premium Premium PremiumChief Medical Officer
2024-04-15 Premium
acquired
Premium Premium PremiumChief Medical Officer
2024-04-15 Premium
sold (taxes)
Premium Premium PremiumInterim CEO & General Counsel
2024-04-15 Premium
acquired
Premium Premium PremiumInterim CEO & General Counsel
2024-04-15 Premium
sold (taxes)
Premium Premium PremiumChief Operating Officer
2024-04-15 Premium
acquired
Premium Premium PremiumChief Operating Officer
2024-03-04 Premium
sold (taxes)
Premium Premium PremiumChief Medical Officer
2024-03-04 Premium
acquired
Premium Premium PremiumChief Medical Officer
2024-03-04 Premium
sold (taxes)
Premium Premium PremiumInterim CEO & General Counsel
2024-03-04 Premium
acquired
Premium Premium PremiumInterim CEO & General Counsel
2024-03-04 Premium
sold (taxes)
Premium Premium PremiumChief Operating Officer
2024-03-04 Premium
acquired
Premium Premium PremiumChief Operating Officer
2024-02-20 Premium
bought
Premium Premium Premium-
2024-02-20 Premium
bought
Premium Premium Premium-
2024-02-20 Premium
bought
Premium Premium Premium-
2024-01-16 Premium
acquired
Premium Premium PremiumChief Operating Officer
2024-01-16 Premium
sold (taxes)
Premium Premium PremiumChief Medical Officer
2024-01-16 Premium
acquired
Premium Premium PremiumChief Medical Officer
2024-01-16 Premium
acquired
Premium Premium PremiumInterim CEO & General Counsel

Rows per page:

1–25 of 50